Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq
Other stock markets
 23:00:00 17/06/2024 BST 		5-day change 1st Jan Change
0.4071 USD -10.17% Intraday chart for The Oncology Institute, Inc. -9.53% -80.04%
05-14 Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14 The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Year 2024
The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
The Oncology Institute Q4 Loss Widens, Revenue Increases
The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2024
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
MaxHealth & The Oncology Institute, Inc. Expand Value-Based Care Partnership
The Oncology Institute Expands Its Specialty Medication Business by Opening Pharmacy Operations in California
Oncology Institute Insider Sold Shares Worth $118,581, According to a Recent SEC Filing
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Year 2023
The Oncology Institute, Inc. Names Jeremy Castle as Chief Operations Officer
The Oncology Institute Regains Compliance With Nasdaq's Minimum Closing Bid Price Rule
The Oncology Institute, Inc. Appoints Jeremy N. Castle as Chief Operations Officer
The Oncology Institute, Inc. Announces Resignation of Ravi Sarin as Member of the Board of Directors and Committees
The Oncology Institute, Inc. announces an Equity Buyback for 2,000,000 shares, for $2 million.
The Oncology Institute, Inc. authorizes a Buyback Plan.
Oncology Institute Signs Agreement With Ambience Healthcare to Adopt AI Operating System for Oncology Care
The Oncology Institute, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TOI Stock
  4. News The Oncology Institute, Inc.
  5. Other languages